News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jun 26, 2007

Jun 26, 2007

Diluting H5N1 vaccine may protect more people, study says

(CIDRAP News) – Limited supplies of prepandemic influenza vaccine may prevent more illness cases overall if they are administered to more people in lower-than-recommended doses, University of Hong Kong researchers contend in a study published this month in Public Library of Science (PLoS) Medicine.

Apr 12, 2007

Apr 12, 2007

Insect-cell-based flu vaccine looks good in clinical trial

(CIDRAP News) – An influenza vaccine grown in insect cells instead of chicken eggs proved safe and yielded a good immune response in a trial in healthy adults, possibly signaling a significant advance in flu vaccine production technology, according to a report published this week in the Journal of the American Medical Association (JAMA).

Mar 07, 2007

Mar 07, 2007

Iowa group bets on market to predict pandemics

(CIDRAP News) – Some professors at the University of Iowa think that a kind of betting system may help predict the timing and extent of the next influenza pandemic, and a large health foundation is betting they are right.

Feb 06, 2007

Feb 06, 2007

2007 SUMMIT COVERAGE: CDC chief calls pandemic preparedness a marathon

(CIDRAP News) – Orlando, FL – Julie Gerberding, MD, director of the Centers for Disease Control and Prevention (CDC), today challenged health and business leaders to stay focused on the "marathon" of preparing for an influenza pandemic.

Gerberding, speaking at a conference on business preparedness, said it's not possible to maintain high public interest in the pandemic threat indefinitely, but leaders must keep preparing anyway.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»